VMP 15457511000001109

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Levodopa 75mg / Carbidopa 18.75mg / Entacapone 200mg tablets
BNF code 0409010X0AAAEAE
Virtual Therapeutic Moiety Levodopa + Carbidopa + Entacapone
Basis of preferred name Other
Date of name applicability 3 Feb 2016
Previous name Generic Stalevo 75mg/18.75mg/200mg tablets
Basis of previous name Other
Reason for name change New approved generic name available
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Entacapone
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 200.000
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Carbidopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 18.750
Strength value numerator unit mg
Virtual Product Ingredient
Ingredient Levodopa
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 75.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Sastravi 75mg/18.75mg/200mg tablets (Accord-UK Ltd)
Stalevo 75mg/18.75mg/200mg tablets (Abacus Medicine Ltd)
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
Stanek 75mg/18.75mg/200mg tablets (Teva UK Ltd)
Virtual Medicinal Product Packs
Levodopa 75mg / Carbidopa 18.75mg / Entacapone 200mg tablets 100 tablet
Levodopa 75mg / Carbidopa 18.75mg / Entacapone 200mg tablets 30 tablet

dm+d data retrieved from TRUD: release NHSBSA_4.2.0_20240415000001, imported on 15th April 2024 at 05:09:22.

Feedback